Well they are concurrently exploring both the original topical and also IV preparations of fluorescein and discussing with manufacturers how best to meet the FDA regulatory requirements relating to fluorescein. So they are tackling it head on and attempting to find a solution that will ultimately open further possibilities for surgical imaging applications.
Ann: OIL June 2024 Quarterly Report and Appendix 4C, page-7
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
-0.015(9.09%) |
Mkt cap ! $125.3M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.5¢ | 15.0¢ | $8.513K | 54.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 118332 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 19676 | 2 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| OIL (ASX) Chart |